[1]
“A Comparative Study of Health Utility Value and in Type 2 Diabetes Mellitus Patients Treated With Oral Monotherapy or In Combination with Oral or Insulin”, jfu, vol. 15, no. 1, Aug. 2026, doi: 10.24843/JFU.2026.v15.i01.p01.